"With its innovative use of virtual twins, ARTEMIs brings hope for earlier interventions, fewer complications, and improved quality of life for patients." Milan Mishkovikj, ELPA Board Member

🔗 artemis-euproject.eu

"ARTEMIs will empower doctors with better tools to personalise care, ensuring patients receive the right treatment at the right time." Tove Frisch

ARTEMIs brings together science, innovation, and patient voices to transform the future of liver and heart health.
Learn more: artemis-euproject.eu

💡 Did you know?
ARTEMIS Clinical Case 3 investigates cardiovascular complications after TIPS placement, predicting cardiovascular events and evaluating overall survival and cirrhosis outcomes.
#LiverHealth #PortalHypertension #ARTEMISEU

💡 Did you know?
ARTEMIS Clinical Case 2 explores fibrosis-associated heart failure patients, focusing on predicting incidence events in MASLD and evaluating the impact of hepatic fibrosis and MASH on early cardiovascular risk.
#LiverHealth #CardioRisk #ARTEMISEU

Did you know?
One of ARTEMIS’ clinical cases studies fibrosis progression in #MASLD patients. The goal: predict outcomes such as transplant needs, liver failure, or cancer – and improve patient care.
#LiverHealth #InnovationInMedicine

💡 Did you know?
ARTEMIS Work Package 9 focuses on exploitation & sustainability – protecting intellectual property, promoting project results, and ensuring long-term impact.
#Innovation #Sustainability #ARTEMISEU

🚨 Revolutionizing liver healthcare! ARTEMIS is using virtual twins & digital modeling to fight #MASLD and improve patient lives. 🌍💡✨ #InnovationInMedicine #LiverHealth